Related Experiment Video
Updated: Jun 1, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
ICSNPathway: identify candidate causal SNPs and pathways from genome-wide association study by one analytical
Kunlin Zhang1, Suhua Chang, Sijia Cui
1Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China.
Nucleic Acids Research
|May 31, 2011
Summary
This study introduces ICSNPathway, a novel web server for interpreting genome-wide association study (GWAS) data. It identifies causal single nucleotide polymorphisms (SNPs) and their associated pathways, bridging the gap between genetic associations and biological mechanisms.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Genome-wide association studies (GWAS) identify genetic variants linked to complex traits and diseases.
- Interpreting GWAS data to pinpoint causal single nucleotide polymorphisms (SNPs) and their biological mechanisms remains a significant challenge.
- Existing pathway-based analysis (PBA) methods do not sufficiently focus on causal SNP interpretation.
Purpose of the Study:
- To develop an integrated analytical framework for identifying candidate causal SNPs and their associated pathways from GWAS data.
- To provide a web server solution for comprehensive GWAS data interpretation, linking genetic variants to biological pathways.
- To generate hypotheses on SNP → gene → pathway relationships for complex traits.
Main Methods:
- Integration of linkage disequilibrium (LD) analysis, functional SNP annotation, and pathway-based analysis (PBA).
- Development of the ICSNPathway web server to streamline the analysis process.
- Focus on identifying candidate causal SNPs and their corresponding pathways.
Main Results:
- ICSNPathway successfully integrates multiple analytical approaches for GWAS interpretation.
- The developed framework aids in identifying potential causal SNPs and their relevant biological pathways.
- Provides a novel solution for bridging the gap between GWAS findings and mechanistic studies.
Conclusions:
- ICSNPathway offers a feasible solution for interpreting GWAS data by identifying candidate causal SNPs and pathways.
- The tool facilitates the generation of testable hypotheses regarding the genetic architecture of complex diseases.
- The freely available web server enhances the utility of GWAS for biological mechanism discovery.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...